Here are three quick facts.
1. Three investment analysts have given the stock a sell rating, five have given a hold rating and nine have given a buy rating.
2. Brokers have set a one-year consensus target price of $152.31 for the company.
3. Shares of athenahealth closed at $134.04 April 11.
More articles on finance and revenue cycle management:
Meet the online medical billing and coding training company that already has 1 million views on YouTube
5 most-read finance stories: Week of April 4-8
Intermedix names Jack Donahue head of EMS revenue cycle business
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
